Abstract:
A revenue causality analyzer that provides attribution of causality effects for changes in revenue. The analyzer includes a selector for selecting a reference time period and a comparison time period, a receiver configured to receive transaction data including pricing data and volume data about the products at reference and comparison times, a preparer that includes a missing data exchanger and data error corrector, an attributor for attributing causality effects including a price effect, a volume effect, a mix effect an exchange effect, a cost effect, a dividend effect, a loss effect, and an inventory appreciation effect, by analyzing transaction data through a causality equation; and an output. Price effect sums the product of change in price and volume of the products across the products and currencies. Volume effect multiplies change in volume by the revenue per product sold. Mix effect multiplies percent revenue change by the volume of products sold.
Abstract:
Compounds and methods are provided for the treatment of, inter alia, Type II diabetes and other diseases associated with poor glycemic control. The compounds of the invention are orally active.
Abstract:
A control system comprising a timer based controller and a valve wherein the timer-based controller has a fixed period and the timer based controller regularly cycles the valve between a first condition and a second condition with the first portion of the cycle directing a first flow of water through a dispensable material and the remaining portion of the cycle directing a lesser flow of water through the dispensable material.
Abstract:
A control system comprising a timer based controller and a valve wherein the timer-based controller has a fixed period and the timer based controller regularly cycles the valve between a first condition and a second condition with the first portion of the cycle directing a first flow of water through a dispensable material and the remaining portion of the cycle directing a lesser flow of water through the dispensable material.
Abstract:
The present invention relates to a quantitative pricing power and pricing risk score generator and methods therefore, useful in association with an integrated price management system. Such a system may include a segment generator, a segment pricing power analyzer, and a segment pricing risk analyzer. The segment generator may receive or generate segments associated with a customer. Segment generation uses transaction level data which includes product attribute information, market data, and transaction history data. The segment pricing power analyzer and risk analyzer identify pricing power and risk factors, and assign raw scores to each factor, generates a weight for each raw score for each of the pricing power factors, and generates the quantitative pricing power and risk scores for each segment by computing a weighted average of the factors using the generated weights for each of the raw scores. Weights may be assigned according to default values or may be generated via an optimization.
Abstract:
Compounds and methods are provided for the treatment of, inter alia, Type II diabetes and other diseases associated with poor glycemic control. The compounds of the invention are orally active.
Abstract:
An apparatus and method for controlling a water characteristic of a body of water by controlling the cyclic release of a water characteristic material into the body of water with or without the system being responsive to a level of the water characteristic in the body of water.
Abstract:
The invention relates to methods of determining islet cell activity by detecting the level of Archipelin or a fragment thereof and comparing the level to a baseline level or range associated with a known islet cell activity. Such methods are useful in diagnosing and studying the development of diabetes.
Abstract:
Expression of beta-TRP is enriched in islet cells. Introduction of expression cassettes encoding beta-TRP into diabetic islet cells improved glucose-stimulated insulin production. Therefore, the invention provides methods of identifying beta-TRP modulators for treating diabetic individuals and introducing beta-TRP into islet cells
Abstract:
The present invention provides polynucleotides encoding potassium channels as well as methods of using the potassium channels to treat and diagnose diabetes and a predisposition for diabetes.